Use of a peptide enhancing the ability of radiation therapy to kill cancer cells: a patent evaluation of WO2012016918

Author： Xu Jing   Wei Qichun  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.12, 2012-12, pp. : 1485-1487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Use of Therapeutic Peptides to Target and to Kill Cancer Cells

By  

Current Medicinal Chemistry, Vol. 19, Iss. 22, 2012-08 ,pp. : 3794-3804

Bentham Science Publishers

Access to resources Recommend Favorite

Use of an anti-CD200 antibody for prolonging the survival of allografts: a patent evaluation of WO2012106634A1

By Rygiel Tomasz P   Luijk Bart   Meyaard Linde  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 3, 2013-03 ,pp. : 389-392

Informa Healthcare

Access to resources Recommend Favorite

Polymyxin derivatives: a patent evaluation (WO2012168820)

By Wu Haifan  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 1075-1081

Informa Healthcare

Access to resources Recommend Favorite

Targeted antimicrobial moieties (WO2010080819): patent evaluation

By Song Zhong-Cheng   Zhu Hai-Liang  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 4, 2011-04 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic compounds: patent evaluation of WO2011011652A1

By Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1491-1495

Informa Healthcare

Access to resources Recommend Favorite